1,3-DMAA

Molecular structure via molpic based on CDK

Physical properties []
Molecular mass	115.22 g/mol ^[1]
Density	0.7655 g/cu cm at 20 °C g/cm³ ^[1]
Appearance	Liquid ^[1]
Odor	Amine odor ^[1]
Boiling point	132.5 °C ^[1]
Solubility	Slightly soluble in water; very soluble in ethanol, ether, chloroform and dilute acid ^[1]
Predicted LogP	1.9 ^[1]

Structural Identifiers []
Molecular formula	C₇H₁₇N ^[1]
IUPAC name	4-methylhexan-2-amine ^[1]
SMILES	CCC(C)CC(C)N ^[1]
InChI	InChI=1S/C7H17N/c1-4-6(2)5-7(3)8/h6-7H,4-5,8H2,1-3H3 ^[1]
InChIKey	YAHRDLICUYEDAU-UHFFFAOYSA-N ^[1]

Dosing []
Elimination half-life	~8.5 hours

Methylhexanamine

Methylhexanamine (also known as 1,3-Dimethylpentylamine, Methylhexaneamine, Forthane, 2-Amino-4-methylhexane, 1,3-Dimethylamylamine, Forthan, 2-Hexanamine, 4-methyl-, 4-Methyl-2-hexylamine, 4-Methyl-2-hexanamine or Dimethylamylamine)

Chemistry

Stereochemistry []

Methylhexanamine is a mixed mixture

Subjective effects []

Physical effects
Abnormal heartbeat Appetite suppression Dehydration Dry mouth Increased blood pressure Increased heart rate Increased libido Restless legs Shakiness Stamina enhancement Stimulation Teeth grinding Vasoconstriction

Cognitive effects
Analysis enhancement Cognitive euphoria Compulsive redosing Disinhibition Ego inflation Focus enhancement Increased music appreciation Mania Motivation enhancement Suggestibility suppression Thought acceleration Wakefulness

Legal status []

Australia: Methylhexanamine is a S10 substance.
Brazil: Methylhexanamine is a F2 substance.^[3]
United States: Methylhexanamine is a Unapproved drug; use in dietary supplements, food, or medicine is unlawful. substance.^[4]^[5]^[6]^[7]

External links []

References []

National Center for Biotechnology Information. PubChem Compound Summary for CID 7753, Methylhexanamine. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/7753
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methylhexanamine. UNII: X49C572YQO. Global Substance Registration System. Accessed June 26, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/X49C572YQO
Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed June 26, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
DMAA: A prohibited stimulant. DoD. October 12, 2022. Accessed June 26, 2025. https://www.opss.org/article/dmaa-prohibited-stimulant
DMAA in Products Marketed as Dietary Supplements. February 22, 2023. Accessed June 26, 2025. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/dmaa-products-marketed-dietary-supplements?ref=smartchoicelist.com
United States v. Hi-Tech Pharmaceuticals, Inc., No. 17-13376 (11th Cir. 2019). August 30, 2019. Accessed June 26, 2025. https://law.justia.com/cases/federal/appellate-courts/ca11/17-13376/17-13376-2019-08-30.html
Meyer H. E. R. Squibb & Sons, inc. et al.; Withdrawal of Approval of New Drug Applications. Food and Drug Administration. November 9, 1983. Accessed June 26, 2025. https://www.govinfo.gov/content/pkg/FR-1983-11-09/pdf/FR-1983-11-09.pdf

Anodyne